Levonorgestrel
DrugBank ID: DB00367
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 2 |
| DL Only | 48 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| acne (disease) | 0.9988 | DL |
| amenorrhea (disease) | 0.9982 | DL |
| postmenopausal osteoporosis | 0.9961 | KG+DL |
| Worth syndrome | 0.9961 | DL |
| breast fibrocystic disease | 0.9948 | DL |
| pregnancy associated osteoporosis | 0.9945 | DL |
| autosomal dominant neovascular inflammatory vitreoretinopathy | 0.9939 | DL |
| benign mammary dysplasia | 0.9914 | DL |
| apocrine adenosis of breast | 0.9902 | DL |
| blunt duct adenosis of breast | 0.9902 | DL |
| succinyl-CoA:3-ketoacid CoA transferase deficiency | 0.9892 | DL |
| breast abscess | 0.9829 | DL |
| fat necrosis of breast | 0.9829 | DL |
| lactation disease | 0.9810 | DL |
| breast adenosis | 0.9755 | DL |
| hypoalphalipoproteinemia | 0.9569 | DL |
| complex regional pain syndrome | 0.9517 | DL |
| osteoporosis | 0.9334 | KG+DL |
| proliferative vitreoretinopathy | 0.9154 | DL |
| zinc, elevated plasma | 0.9149 | DL |
| blindness (disorder) | 0.8942 | DL |
| sebaceous gland anomaly | 0.8730 | DL |
| duodenal ulcer (disease) | 0.8523 | DL |
| scalp dermatosis | 0.8503 | DL |
| humoral hypercalcemia of malignancy | 0.8457 | DL |
| multiple endocrine neoplasia | 0.8397 | DL |
| urticaria, familial localized heat | 0.8352 | DL |
| familial acanthosis nigricans | 0.8348 | DL |
| duodenogastric reflux | 0.8325 | DL |
| familial pityriasis rubra pilaris | 0.8318 | DL |
| osteocraniostenosis | 0.8285 | DL |
| duodenal obstruction | 0.8222 | DL |
| seborrheic keratosis | 0.8198 | DL |
| obsolete familial combined hyperlipidemia | 0.8180 | DL |
| anhidrosis, familial generalized, with abnormal or absent sweat glands | 0.8117 | DL |
| X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome | 0.8096 | DL |
| erythrokeratodermia-cardiomyopathy syndrome | 0.8093 | DL |
| inherited cutis laxa | 0.8023 | DL |
| prolidase deficiency | 0.7938 | DL |
| familial primary localized cutaneous amyloidosis | 0.7934 | DL |
| Tietz syndrome | 0.7891 | DL |
| van den Bosch syndrome | 0.7777 | DL |
| seborrheic dermatitis | 0.7775 | DL |
| deaf blind hypopigmentation syndrome, Yemenite type | 0.7746 | DL |
| vulvar inverted follicular keratosis | 0.7728 | DL |
| HIV infectious disease | 0.7669 | DL |
| aplasia cutis-myopia syndrome | 0.7664 | DL |
| obsolete susceptibility to ischemic stroke | 0.7651 | DL |
| pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa | 0.7599 | DL |
| deafness, congenital, with total albinism | 0.7526 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.